76 related articles for article (PubMed ID: 23861336)
1. Using the ASC:SIL ratio, human papillomavirus, and interobserver variability to assess and monitor cytopathology fellow training performance.
Chebib I; Rao RA; Wilbur DC; Tambouret RH
Cancer Cytopathol; 2013 Nov; 121(11):638-43. PubMed ID: 23861336
[TBL] [Abstract][Full Text] [Related]
2. HPV test result monitoring of different Bethesda categories in gynaecologic cytology: A valuable quality assurance measure.
Goyal A; Street J; Alperstein SA; Siddiqui MT
Diagn Cytopathol; 2018 Nov; 46(11):914-918. PubMed ID: 30353695
[TBL] [Abstract][Full Text] [Related]
3. Non-16/non-18 high-risk human papillomavirus types predominate in anal cytology categories of negative for intraepithelial lesion and atypical cells of undetermined significance.
Chebib I; Tetreault D; Tambouret RH
J Am Soc Cytopathol; 2015; 4(6):344-351. PubMed ID: 31051749
[TBL] [Abstract][Full Text] [Related]
4. High-risk human papillomavirus detection in women with low-grade squamous intraepithelial lesions or higher-grade cytology using the Cervista HPV HR test.
Gold MA; Thomas MA; Huh WK; Sarto GE; Day SP
J Low Genit Tract Dis; 2013 Jan; 17(1):51-7. PubMed ID: 22885641
[TBL] [Abstract][Full Text] [Related]
5. Anal-rectal cytology: correlation with human papillomavirus status and biopsy diagnoses in a population of HIV-positive patients.
Bean SM; Chhieng DC; Roberson J; Raper JL; Broker TR; Hoesley CJ; Eltoum IA; Jin G
J Low Genit Tract Dis; 2010 Apr; 14(2):90-6. PubMed ID: 20354415
[TBL] [Abstract][Full Text] [Related]
6. Bethesda Interobserver Reproducibility Study-2 (BIRST-2): Bethesda System 2014.
Kurtycz DFI; Staats PN; Chute DJ; Russell D; Pavelec D; Monaco SE; Friedlander MA; Wilbur DC; Nayar R
J Am Soc Cytopathol; 2017; 6(4):131-144. PubMed ID: 31043266
[TBL] [Abstract][Full Text] [Related]
7. Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing.
Sherman ME; Schiffman MH; Lorincz AT; Herrero R; Hutchinson ML; Bratti C; Zahniser D; Morales J; Hildesheim A; Helgesen K; Kelly D; Alfaro M; Mena F; Balmaceda I; Mango L; Greenberg M
Cancer; 1997 Apr; 81(2):89-97. PubMed ID: 9126136
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic human papillomavirus testing in an adolescent population with atypical squamous cells of undetermined significance.
Fletcher AH; Wilkinson EJ; Knapik JA
J Low Genit Tract Dis; 2009 Jan; 13(1):28-32. PubMed ID: 19098603
[TBL] [Abstract][Full Text] [Related]
9. HPV detection rate in discordant Pap tests between cytotechnologists and pathologists.
Chhieng DC; Bakdounes K; Connolly M; Gallaspy S; Roberson J; Eltoum I
Diagn Cytopathol; 2009 May; 37(5):320-3. PubMed ID: 19191288
[TBL] [Abstract][Full Text] [Related]
10. HPV DNA testing of the residual sample of liquid-based Pap test: utility as a quality assurance monitor.
Zuna RE; Moore W; Dunn ST
Mod Pathol; 2001 Mar; 14(3):147-51. PubMed ID: 11266518
[TBL] [Abstract][Full Text] [Related]
11. Cytologic diagnosis of atypical squamous cells of undetermined significance in perimenopausal and postmenopausal women: lessons learned from human Papillomavirus DNA testing.
Johnston EI; Logani S
Cancer; 2007 Jun; 111(3):160-5. PubMed ID: 17506090
[TBL] [Abstract][Full Text] [Related]
12. Anal cytology: is there a role for reflex HPV DNA testing?
Walts AE; Thomas P; Bose S
Diagn Cytopathol; 2005 Sep; 33(3):152-6. PubMed ID: 16078257
[TBL] [Abstract][Full Text] [Related]
13. The utility of human papillomavirus testing in the management of atypical glandular cells on cytology.
Sharpless KE; O'Sullivan DM; Schnatz PF
J Low Genit Tract Dis; 2009 Apr; 13(2):72-8. PubMed ID: 19387126
[TBL] [Abstract][Full Text] [Related]
14. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus DNA detection in cervical specimens by hybrid capture: correlation with cytologic and histologic diagnoses of squamous intraepithelial lesions of the cervix.
Hall S; Lörincz A; Shah F; Sherman ME; Abbas F; Paull G; Kurman RJ; Shah KV
Gynecol Oncol; 1996 Sep; 62(3):353-9. PubMed ID: 8812532
[TBL] [Abstract][Full Text] [Related]
16. From Papanicolaou to Bethesda: the rationale for a new cervical cytologic classification.
Kurman RJ; Malkasian GD; Sedlis A; Solomon D
Obstet Gynecol; 1991 May; 77(5):779-82. PubMed ID: 1849626
[TBL] [Abstract][Full Text] [Related]
17. Resolution of equivocal results with the Hybrid Capture II high-risk HPV DNA test: a cytologic/histologic review of 191 cases.
Knoepp SM; Kuebler DL; Wilbur DC
Diagn Mol Pathol; 2007 Sep; 16(3):125-9. PubMed ID: 17721319
[TBL] [Abstract][Full Text] [Related]
18. The degree of agreement between HPV testing, pap smear and colposcopy in cervical dysplasia diagnosis.
Melinte-Popescu A; Costăchescu G
Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):536-9. PubMed ID: 23077949
[TBL] [Abstract][Full Text] [Related]
19. Impact of education on institutional and faculty rates of atypical squamous cells.
Dyhdalo KS; McMeekin E; Brainard JA; Bruening AE; Underwood D; Chute DJ
J Am Soc Cytopathol; 2021; 10(5):517-524. PubMed ID: 34119449
[TBL] [Abstract][Full Text] [Related]
20. The clinical impact of including pictures in Papanicolaou test reports.
Thrall MJ; Janssen BL; Mody DR
J Am Soc Cytopathol; 2015; 4(3):122-127. PubMed ID: 31051692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
